Latest News

Galantamine Supplements Found Mislabeled, Contaminated


 

TOPLINE:

Galantamine purchased as a dietary supplement may be more likely to contain bacterial contaminants and an incorrect amount of the product vs when it is prescribed as a generic drug, new research showed.

METHODOLOGY:

  • Galantamine, a plant alkaloid, is approved for treating mild to moderate Alzheimer’s dementia but is also marketed as a dietary supplement for cognitive enhancement.
  • In June 2023, researchers purchased all 10 galantamine dietary supplements available on Amazon.com that had a Supplement Facts panel.
  • In September 2023, they acquired all 11 generic immediate-release formulations of prescription galantamine available in the United States.
  • They analyzed the content of galantamine in each product using ultrahigh-performance liquid chromatography-mass spectrometry and quantified any microorganisms present.

TAKEAWAY:

  • Generic galantamine drugs were found to contain 97.5%-104.2% of the labeled content, with no microbial contamination.
  • Galantamine dietary supplements, however, showed a wide variance in content, ranging from less than 2% to 110% of the labeled amount, and 30% were contaminated with Bacillus cereus sensu stricto. The amount of bacteria present would not have been expected to harm consumers, according to the authors of the study.

IN PRACTICE:

“Clinicians should query patients with memory concerns about the use of dietary supplements and advise patients not to use galantamine supplements,” the researchers wrote.

SOURCE:

The corresponding author of the study was Pieter A. Cohen, MD, with Broadway Clinic, Cambridge Health Alliance, in Somerville, Massachusetts. The paper was published online as a research letter in JAMA.

LIMITATIONS:

The products were purchased at a single point in time and may not reflect current options, the researchers noted. The generalizability of the findings to other supplement ingredients or generic drugs is unknown.

DISCLOSURES:

Dr. Cohen has received grants from the Consumers Union and PEW Charitable Trust and personal fees from UpToDate and the Centers for Disease Control and Prevention. He has been sued by a supplement company in a case where the jury found in his favor.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

A version of this article appeared on Medscape.com.

Recommended Reading

H pylori Infection Linked to Increased Alzheimer’s Risk
Federal Practitioner
Regular Physical Activity Linked to Larger Brain Volume
Federal Practitioner
Modifiable Risk Factors for Young-Onset Dementia Flagged
Federal Practitioner
Multivitamins and Cognition: New Data From COSMOS
Federal Practitioner
A Healthy Dose of Superstition
Federal Practitioner
Can Pet Ownership Ward Off Cognitive Decline?
Federal Practitioner
First Cases of Medically Acquired Alzheimer’s Disease Reported
Federal Practitioner
Playing Music Tied to Better Cognition in Later Life
Federal Practitioner
Undiagnosed Cirrhosis May Underlie Some Dementia Cases
Federal Practitioner
Bariatric Surgery Yields Significant Cognitive Benefits
Federal Practitioner